Skip to content

GHRP-2 studies: 202 papers with results

Page 3 of 5

  1. The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus.

    Kamegai J · Brain research. Molecular brain research · 1996

    Animal study (in vivo) · rat · 5 results

  2. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.

    Hirotani C · Naunyn-Schmiedeberg's archives of pharmacology · 2005

    Animal study (in vivo) · rat · 7 results

  3. Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.

    Zeng P · Peptides · 2014

    Animal study (in vivo) · mouse · 5 results

  4. Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.

    Alba M · American journal of physiology. Endocrinology and metabolism · 2005

    Animal study (in vivo) · mouse · 4 results

  5. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.

    Kato Y · Circulation journal : official journal of the Japanese Circulation Society · 2010

    Animal study (in vivo) · hamster · 5 results

  6. Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse.

    Fintini D · Neuroendocrinology · 2005

    Animal study (in vivo) · mouse · 5 results

  7. Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice.

    Zeng P · Peptides · 2013

    Animal study (in vivo) · mouse · 2 results

  8. The growth hormone secretagogue KP-102-induced stimulation of food intake is modified by fasting, restraint stress, and somatostatin in rats.

    Shibasaki T · Neuroscience letters · 1998

    Animal study (in vivo) · rat · 4 results

  9. Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice.

    Peroni CN · Clinics (Sao Paulo, Brazil) · 2012

    Animal study (in vivo) · mouse · 3 results

  10. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

    Doi N · Arzneimittel-Forschung · 2004

    Animal study (in vivo) · dog and rat · 13 results

  11. Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats.

    Nakagawa T · Life sciences · 1996

    Animal study (in vivo) · rat · 6 results

  12. The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine.

    Phung LT · Domestic animal endocrinology · 2000

    Animal study (in vivo) · pig · 9 results

  13. Oral administration of peptidergic growth hormone (GH) secretagogue KP102 stimulates GH release in goats.

    Hashizume T · Domestic animal endocrinology · 1999

    Animal study (in vivo) · goat · 10 results

  14. Intrahypothalamic perfusion of KP102 stimulates growth hormone release in goats.

    Hashizume T · Endocrine journal · 1998

    Animal study (in vivo) · goat · 3 results

  15. Effect of D-Ala-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2 (KP-102) on GH secretion in urethan-anesthetized rats.

    Sawada H · Regulatory peptides · 1994

    Animal study (in vivo) · rat · 6 results

  16. Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.

    Li Y · Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association · 2025

    Animal study (in vivo) · rat · 12 results

  17. Plasma growth hormone (GH) responses after administration of the peptidergic GH secretagogue KP102 into the oral cavity, rumen, abomasum and duodenum in adult goats.

    Hashizume T · Domestic animal endocrinology · 2001

    Animal study (in vivo) · goat · 6 results

  18. [Effect of newly developed analogue of growth hormone releasing peptide [D-Ala-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2 (KP-102)] on growth hormone secretion in adult male rats].

    Sawada H · Nihon Ika Daigaku zasshi · 1995

    Animal study (in vivo) · rat · 6 results

  19. Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat.

    Zhang X · BioMed research international · 2014

    Animal study (in vivo) · rat · 1 result

  20. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

    Furuta S · Arzneimittel-Forschung · 2004

    Animal study (in vivo) · 9 results

  21. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

    Johansen PB · Xenobiotica; the fate of foreign compounds in biological systems · 1998

    Animal study (in vivo) · rat · 11 results

  22. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.

    Adams EF · Molecular endocrinology (Baltimore, Md.) · 1996

    Ex vivo tissue · 16 results

  23. Effect of growth hormone-releasing peptide-2 (GHRP-2) and GH-releasing hormone (GHRH) on the the cAMP levels and GH release from cultured acromegalic tumours.

    Chen C · Journal of neuroendocrinology · 1998

    Ex vivo tissue · 9 results

  24. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells.

    Adams EF · The Journal of clinical endocrinology and metabolism · 1998

    Ex vivo tissue · 10 results

  25. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.

    Kwok WH · Analytical and bioanalytical chemistry · 2013

    Ex vivo tissue · horse · 12 results

  26. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.

    Deghenghi R · Endocrine · 2001

    Ex vivo tissue · 4 results

  27. KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts.

    Furuta S · Naunyn-Schmiedeberg's archives of pharmacology · 2006

    Ex vivo tissue · rat · 9 results

  28. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc.

    Mano-Otagiri A · Endocrinology · 2006

    In vitro (cells) · 5 results

  29. Human fetal pituitary expresses functional growth hormone-releasing peptide receptors.

    Shimon I · The Journal of clinical endocrinology and metabolism · 1998

    In vitro (cells) · 9 results

  30. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.

    Wu D · The Journal of endocrinology · 1996

    In vitro (cells) · rat and sheep · 26 results

  31. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist.

    Wu D · The Journal of endocrinology · 1994

    In vitro (cells) · sheep · 10 results

  32. The role of protein kinase C in GH secretion induced by GH-releasing factor and GH-releasing peptides in cultured ovine somatotrophs.

    Wu D · The Journal of endocrinology · 1997

    In vitro (cells) · sheep · 10 results

  33. Effects of growth hormone-releasing peptide-2 (GHRP-2) on membrane Ca2+ permeability in cultured ovine somatotrophs.

    Chen C · Journal of neuroendocrinology · 1995

    In vitro (cells) · sheep · 7 results

  34. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.

    Yan M · European journal of endocrinology · 2004

    In vitro (cells) · sheep · 7 results

  35. Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells.

    Tsukamoto N · Molecular and cellular endocrinology · 2011

    In vitro (cells) · mouse · 12 results

  36. Growth hormone-releasing peptide-2 reduces inward rectifying K+ currents via a PKA-cAMP-mediated signalling pathway in ovine somatotropes.

    Xu R · The Journal of physiology · 2002

    In vitro (cells) · sheep · 6 results

  37. Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells.

    Cheng J · Life sciences · 1997

    In vitro (cells) · rat · 8 results

  38. Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH.

    Roh SG · Endocrine · 2006

    In vitro (cells) · ovine · 10 results

  39. The effects of ghrelin/GHSs on AVP mRNA expression and release in cultured hypothalamic cells in rats.

    Nemoto T · Peptides · 2011

    In vitro (cells) · rat · 7 results

  40. Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells.

    Roh SG · Journal of animal science · 1997

    In vitro (cells) · cattle · 7 results

  41. The effect of two-day treatment of primary cultured ovine somatotropes with GHRP-2 on membrane voltage-gated K+ currents.

    Chen C · Endocrinology · 2002

    In vitro (cells) · sheep · 9 results

  42. Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells.

    Chao YN · International journal of molecular sciences · 2016

    In vitro (cells) · 9 results

  43. Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary.

    Kageyama K · Regulatory peptides · 2009

    In vitro (cells) · mouse · 8 results

  44. The effect of GHRH, GHRP-2 and somatostatin on GH secretion by fetal pituitary.

    Liu Q · Journal of Tongji Medical University = Tong ji yi ke da xue xue bao · 1999

    In vitro (cells) · 1 result

  45. Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.

    Chen C · Endocrine · 1998

    In vitro (cells) · rat · 4 results

  46. Neurokinin receptor antagonists inhibit the binding of growth hormone-releasing peptide to EP-1 human neuroblastoma cells.

    Tai S · Biochemical and biophysical research communications · 1995

    In vitro (cells) · 3 results

  47. The role of growth hormone third regulatory pathway in growth hormone releasing of human pituitary growth hormone adenoma

    Lei Ting · Zhonghua shi yan wai ke za zhi = Zhonghua shiyan waike zazhi = Chinese journal of experimental surgery · 1999

    In vitro (cells) · 2 results

  48. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.

    Muccioli G · The Journal of endocrinology · 1998

    In vitro (cell-free) · 9 results

  49. In vitro models for metabolic studies of small peptide hormones in sport drug testing.

    Esposito S · Journal of peptide science : an official publication of the European Peptide Society · 2015

    In vitro (cell-free) · 6 results

  50. Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.

    Kanhed AM · Molecular diversity · 2021

    In silico · 1 result

How PepBank reports evidence